Animals
All adult male Sprague-Dawley rats weighing 200–250 g in the study were provided by the Experimental Animal Center of Chongqing Medical University (Chongqing, China). All animals were housed in a temperature-controlled (23 ± 1°C) environment under a 12-h light/dark cycle, and all animals were allowed to access food and water freely. Before any experimental procedures were performed, all animals were acclimated for at least 7 days. The study was carried out after being approved by the Ethics Committee of the Department of Medical Research at the First Affiliated Hospital of Chongqing Medical University and all the experiments were conducted in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals (NIH Publications No. 80–23, revised 1996).
Surgery
The surgical procedures were performed as previously reported[19, 20]. Briefly, rats were deeply anaesthetized with 1% pentobarbital sodium (i.p., 40mg/kg body weight)and then placed on a stereotaxic apparatus (ST-51603; Stoelting Co, Chicago, IL, USA). An incision was used to expose the skull completely, and a skull drill was used to perform 1-mm-diameter craniotomy in the right frontal bone (+ 1.5 mm from the bregma and + 1.5 mm lateral to the bregma), taking care not to damage the dura. Afterwards, a sterile stainless-steel cannula with a plastic cup was placed above the dura and affixed to the skull for delivery of IS or phosphate-buffered saline (PBS) through the cranial window. A matched obturator cap was used to seal the cannula. The skin was sutured with 4-0 nylon. After surgery, antibiotics were topically applied to prevent any infections in the operation region. Postoperative rats were placed on a thermostatic plate that was maintained at approximately 37°C until they were awake and completely mobile. The rats were housed separately and recovered for at least 7 days. After 7 days, the rats in which the surgical site was not infected and the cannula was not blocked were selected to enter the following experiment.
Infusion of inflammatory soup or PBS
The CM rat model was established by repeated infusions of IS into the dura. The rats were randomized into two groups (sham and CM) and infused with IS or PBS for 7 days as previously described [19]. The rats in the CM group were infused with 2 μl of IS, and the rats in the sham group were infused with the same volume of PBS. The inflammatory soup (IS) contained 1 mM histamine, 1 mM serotonin, 1 mM bradykinin, and 0.1 mM prostaglandin E2 in PBS (pH 7.4) (adapted from St. Louis, MO, USA). Each rat was steadily infused with 2 μl of IS or PBS for 10 min via the cannula. The tube was left in place for at least 5 min after infusion to allow the IS or PBS to diffuse into the tissue surrounding the dura, and the cap was returned to the cannula after the infusion. The rats were allowed to move freely throughout the entire procedure.
Drug administration
SRT1720 (S1129, Selleckchem), an activator of SIRT1, was intracerebroventricularly injected for three consecutive days after the 7th IS or PBS infusion. The SRT1720 was dissolved by dimethylsulphoxidein dimethylsulfoxide (DMSO). For SRT1720 administration, there were two subgroups: the CM+SRT1720 LD group (low dose, 10 μg) and the CM+SRT1720 HD group (high dose, 30 μg). The doses of SRT1720 were based on previous studies [21-23]. Intracerebroventricular injections were conducted as described previously [24]. After anesthesia, SRT1720 was injected into the lateral ventricle (-1.0 mm posterior and +1.5 mm lateral to the bregma; 4.0 mm from the skull plane) with the designated treatment solution (10 μl). An equal volume of DMSO was injected into the lateral ventricle as a corresponding vehicle control (CM+DMSO group). The rats were randomly divided into the treatment groups during the injection process.
Assessment of mechanical sensitivity and thermal hyperalgesia
The von Frey test was used to detect the mechanical threshold in the periorbital and hind paw regions. Briefly, rats were placed in a test device and adapted to the test device for 30 min before testing. The pressure threshold was determined by applying an electronic von Frey device (Electrovonfrey, model: 2450, IITC Inc., Woodland Hills, CA, USA) with assigned force values ranged from 0 to 900 g. The pressure probe tip was applied to the periorbital and hind paw regions of the rat according to the manufacturer's instructions, and the threshold was automatically recorded. The stimulation of the test was very mild at the beginning, and the stimulation increased gradually until the rats showed a positive reaction. Rapid withdrawal of the head or hind paw in response to the stimulus was considered a positive response. Each site was tested at least three times with a continuous stimulation interval of 1 min. The results for the PBS group were considered to indicate the control mechanical threshold.
Thermal hyperalgesia was classified as a significantly shortened latency of thermal stimulation of the foot. An analgesia meter (model PL-200, IITC, Taimeng, Chengdu, China) was used to test the threshold of thermal hyperalgesia. The protocol was similar to that described previously[25]. Briefly, rats were placed in a box (20*20*20 cm), and the heat source was concentrated on a portion of the hind paw of each rat. The radiant heat stimulus was delivered to the site, and the intensity of the heat source was stetted at 20%. When the hind paw moved or to prevent tissue damage after 20 seconds had passed, the stimulus ceased automatically. In all experiments, the intensity of the thermal stimulus remained consistent. The thermal stimulation was delivered to each hind paw 3 times at intervals of 5-8 mins.
To determine the effects of SRT1720 and its corresponding vehicle (DMSO) on the mechanical threshold and on thermal hyperalgesia, the same test was conducted 24 h after administration of SRT1720 or DMSO. The results are presented as the threshold in g ± the standard deviation (SD). The data were recorded separately for each time point. During the testing period, the experimenter was blinded to the groups.
Quantitative real-time polymerase chain reaction (q-PCR)
q-PCR was used to detect the mRNA expression of SIRT1 and PGC-1α. Total RNA was extracted from the TNC with RNAiso reagent (TaKaRa, Dalian, China) according to the manufacturer’s instructions, and cDNA was synthesized with a PrimeScriptTM RT Reagent Kit (TaKaRa). q-PCR to quantify SIRT1 and PGC-1α gene expression was performed with SYBR® Premix Ex TaqTM II (TaKaRa). The gene expression is expressed as the target/reference gene expression ratio, which was determined with a post-PCR data analysis software program. The primer pairs specific for rat SIRT1, PGC-1α and GAPDH were as follows:
SIRT1(F): 5’-AAGGCCACGGATAGGTCCA -3’,SIRT1(R): 5’-CCGCTTTGGTGGTTCTGAAAG-3’,
PGC-1α(F): 5’-GAATGCCCGCGAACATAT-3’, PGC-1α(R): 5’-CAATCCGTCTTCATCCACCG-3’,
GAPDH(F): 5’-GCAAGTTCAACGGCACAG-3’, and GAPDH(R): 5’-GCCAGTAGACTCCACGACAT-3’. The primers for SIRT1, PGC-1α and GAPDH were synthesized by Sangon Biotech (Shanghai, China). The reactions were incubated at 95°C for 30 s and then subjected to 45 cycles of 95°C for 5 s and 55°C for 30 s in a CFX96 Touch thermocycler (Bio-Rad, USA).
Determination of mitochondrial DNA content
Total DNA was extracted from the TNC with a mammalian genomic DNA extraction kit (Beyotime Biotechnology, Shanghai, China) following the manufacturer’s instructions. q-PCR was performed with SYBR® Premix Ex TaqTM II (TaKaRa). The relative mtDNA copy numbers were determined by comparing the expression of the specific mitochondrial gene ND1 to that of the GAPDH gene by the 2−△△CT method. The primer pairs specific for rat ND1 and GAPDH were as follows: ND1(F): 5’-GTAATTGCGTAAGACTTAAAACC-3’ , ND1(R): 5’-CCTAGAAATAAGAGGATTTAAACC-3’,
GAPDH(F): 5’-GCAAGTTCAACGGCACAG-3’, and GAPDH(R): 5’-GCCAGTAGACTCCACGACAT-3’. The primers for ND1 and GAPDH were synthesized by Sangon Biotech (Shanghai, China). The reactions were incubated at 95°C for 30 s and then subjected to 45 cycles of 95°C for 5 s and 55°C for 30 s in a CFX96 Touch thermocycler (Bio-Rad, USA).
Western blot analysis
Western blot analysis was used to detect the expression of SIRT1, PGC-1α, TFAM, NRF-1, NRF-2 and CGRP in the TNC (trigeminal nucleus caudalis). The left TNC was isolated immediately for further protein and gene analysis. The tissues were homogenized in RIPA lysis buffer (Beyotime, Shanghai, China) with protease inhibitor (Beyotime). The protein concentration was determined with a BCA Protein Assay Kit (Beyotime, Shanghai, China). Equal amounts of protein (40 μg) were loaded onto SDS-PA gels (Beyotime, China), electrophoresed, and transferred to PVDF membranes. Then, the membranes were blocked for 2 h at room temperature in TBST containing 5% nonfat milk and incubated at 4°C overnight with antibodies against SIRT1 (1:3000, Abcam, MA, USA), PGC-1α (1:2000, Proteintech, IL, USA), TFAM (1:1000, Novus Biologicals, Cambridge, UK), NRF-1 (1:2000, Proteintech), NRF-2 (1:2000, Proteintech), CGRP (1:3000, Abcam), and β-actin (1:5000, Proteintech). The next day, the membranes were incubated with horseradish peroxidase-conjugated anti-rabbit or anti-mouse secondary antibodies (1:5000, Zhongshan Golden Bridge Bio, Beijing, China) at 37 °C for 1 h. Antibody binding was visualized with a western blot detection kit (Advansta, USA) and an imaging system (Fusion, Germany). The same software was used for densitometry. β-actin was used as an internal reference to normalize the protein levels.
Immunofluorescence staining
Under deep anesthesia, rats were transcardially perfused with 0.1 M PBS and then with 4% paraformaldehyde in 0.1 M PBS (pH 7.4). The regions from medulla oblongata to the first cervical cord were separated immediately, postfixed in 4% paraformaldehyde for 24 h, and then sequentially immersed in solutions of sucrose at increasing concentrations (20% to 30%) until the tissues sank to the bottom. Segments of the TNC were cut into 10-μm-thick sections with a cryostat (Leica, Japan). The immunoreactivities of SIRT1, PGC-1α, CGRP and SP in the TNC were detected by immunofluorescence staining. First, the sections were rinsed three times with 0.1 M PBS. Following incubation with 0.3% Triton X-100 (Beyotime) for 10 min, the sections were blocked using 10% normal goat serum (Boster, Wuhan, China) at 37°C for 30 min. Then, the sections were incubated with one of the following primary antibodies at 4°C overnight: a rabbit anti-SIRT1 antibody (1:200, Bioss, China), a mouse anti-NeuN antibody (1:200, Novus Biologicals, CO, USA), a mouse anti-PGC-1α antibody (1:200, Proteintech), a rabbit anti-NeuN antibody (1:400, Novus Biologicals, CO, USA), a mouse anti-CGRP antibody (1:50, Santa Cruz Biotechnology, CA, USA) or a mouse anti-SP antibody (1:50, Abcam). The next day, the sections were incubated with species-specific fluorophore-labeled secondary antibodies (1:400, Abbkine) for 2 h at 37°C. Then, the sections were washed in PBS three times, and the nuclei were counterstained with 4′,6-diamidino-2-phenylinodole (DAPI) at 37 °C for 10 min. A confocal laser scanning fluorescence microscope (Zeiss, LSM 800, Germany) was used for visualization. The 20x objective was used to image SIRT1- and PGC-1α-immunoreactive cells. The bilateral immunoreactivity of CGRP and SP in the TNC was imaged with a 10x objective. The fluorescence intensities of CGRP and SP in the TNC were determined with ImageJ software (version 1.4.3.67, NIH) and are presented as the mean fluorescence intensities (total fluorescence intensity/area).
Determination of ATP content
Tissue ATP content was determined with an Enhanced ATP Assay Kit (Beyotime, China) following the manufacturer’s instructions. The total ATP levels were calculated from the luminescence signals and were normalized by the protein concentrations.
Mitochondrial membrane potential determination
The mitochondrial membrane potential was measured with a JC-1 assay kit (Beyotime) according to the manufacturer’s instructions. Fresh mitochondria were immediately isolated with a Tissue Mitochondria Isolation Kit (Beyotime) according to the manufacturer’s instructions. JC-1 fluorescence was measured with a fluorescence microplate reader (M200, Tecan, Switzerland) under a single excitation wavelength (488 nm) and dual emission wavelengths (a shift from 530 to 590 nm). The changes in mitochondrial membrane potential were indicated by the ratios of the green and red fluorescence intensities.
Transmission electron microscopy
Rats were deeply anesthetized and perfused with 0.1 M phosphate-buffered saline (PBS, pH 7.4) followed by 2.5% glutaraldehyde for fixation. The TNC of each rat was separated and incubated in 4% glutaraldehyde at 4°Cfor 24 h. Then, the TNC was cut into 1 mm3 pieces. Postfixing, embedding, sectioning and staining were performed at Chongqing Medical University. Five samples were selected randomly from each rat and imaged at 50,000x magnification to assess mitochondrial ultrastructure.
Statistical analysis
All data are expressed as the mean ± SD. Statistical comparisons among groups were performed using t-tests or one-way analysis of variance (ANOVA) followed by the Bonferroni post hoc test. The mechanical thresholds for the sham and CM groups were assessed by using two-way analysis of variance followed by the Bonferroni post hoc test. P< 0.05 was considered to indicate statistical significance in all tests. Statistical analyses were performed in SPSS 22.0 (SPSS Inc., Chicago, IL, USA), and graphs were generated with GraphPad Prism 7 (GraphPad Software, San Diego, CA).